Emily Rout

Dr. Emily Rout


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2019 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
EREmily Rout
Emily Rout
RBRobert C. Burnett
Robert C. Burnett
JYJanna A. Yoshimoto
Janna A. Yoshimoto
PAPaul R. Avery
Paul R. Avery
AAAnne C. Avery
Anne C. Avery

10 February 2017 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
EREmily Rout
Emily Rout
ASAlba Maria M. Shank
Alba Maria M. Shank
AWAngharad H. K. Waite
Angharad H. K. Waite
ASAndrea Siegel
Andrea Siegel
AAAnne C. Avery
Anne C. Avery
PAPaul R. Avery
Paul R. Avery

1 January 2016 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
JBJ.L. Bromberek
J.L. Bromberek
EREmily Rout
Emily Rout
MAM.R. Agnew
M.R. Agnew
JYJ. Yoshimoto
J. Yoshimoto
PMPaul S Morley
Paul S Morley
AAA.C. Avery
A.C. Avery
Background: B-cell chronic lymphocytic leukemia (B-CLL) is the most common hematopoietic malignancy in humans in the developed world and the primary risk factor is genetic. Dogs also develop B-CLL, but there is no systematic description of the disease in dogs. Understanding the epidemiology of B-CLL in dogs may help practitioners recognize the disease and position the dog as a model for future genetic studies. Objectives: To describe B-CLL presentation in dogs, its clinicopathologic findings, and breed predisposition. Animals: Four hundred and ninety-one dogs with B-CLL and 5,673 control dogs with suspicion of a lymphoproliferative disorder (LPD). Methods: Retrospective cross-sectional study of dogs for which samples were submitted to the Colorado State University Clinical Immunology Laboratory for immunophenotyping between 2010 and 2014. To assess breed predilection, dogs with B-CLL were compared to those with suspicion of other LPDs using logistic regression. Results: The median age was 11 years with no sex predilection. Half of the dogs presented with peripheral lymphadenopathy or splenomegaly and 26% had anemia. Eleven small-breed dogs had significantly increased odds of B-CLL. In addition, English Bulldogs had an increased risk and a unique presentation: these dogs were diagnosed at a median of 6 years and expressed lower class II MHC and CD25. Conclusions: B-cell chronic lymphocytic leukemia is overrepresented in small-breed dogs. Future genetic studies of these breeds may identify genetic risk factors. The unique presentation of English Bulldogs provides evidence of multiple forms of this disease. Additional studies are necessary to determine whether presenting signs are associated with survival.

1 January 2017 in Veterinary Clinics of North America: Small Animal Practice
Verified
Journal Article
Closed access
EREmily Rout
Emily Rout
PAPaul R. Avery
Paul R. Avery

26 October 2019 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
LCLydia J. Colopy
Lydia J. Colopy
KSKai-Biu Shiu
Kai-Biu Shiu
LSLaura A. Snyder
Laura A. Snyder
AAAnne C. Avery
Anne C. Avery
EREmily Rout
Emily Rout
AMA R. Moore
A R. Moore
Immunoglobulin G4-related disease (IgG4-RD), which affects many organ systems, has been recognized as a distinct clinical entity in human medicine for just over a decade but has not been previously identified in dogs. In humans, IgG4-RD is characterized by diffuse IgG4-positive lymphoplasmacytic infiltrates that commonly lead to increased serum concentrations of IgG4 and IgE, peripheral eosinophilia, tumorous swellings that often include the parotid salivary glands, obliterative phlebitis, and extensive fibrosis. Herein we describe the diagnosis, clinical progression, and successful treatment of IgG4-RD in an 8-year-old female spayed Husky mixed breed dog. Immunoglobulin G4-related disease should be considered as a differential diagnosis for dogs with vague clinical signs, lymphoplasmacytic swellings, restricted polyclonal gammopathy, eosinophilia or some combination of these findings.

17 May 2021 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
EREmily Rout
Emily Rout
JLJulia D. Labadie
Julia D. Labadie
JYJanna A. Yoshimoto
Janna A. Yoshimoto
PAPaul R. Avery
Paul R. Avery
KCKaitlin M. Curran
Kaitlin M. Curran
AAAnne C. Avery
Anne C. Avery
Background B‐cell chronic lymphocytic leukemia (BCLL) in dogs generally is considered an indolent disease, but previous studies indicate a wide range in survival times. Objectives We hypothesized that BCLL has a heterogeneous clinical course, similar to chronic lymphocytic leukemia in humans. We aimed to assess presentation and outcome in dogs with BCLL and evaluate the prognostic relevance of clinical and flow cytometric factors. Animals One hundred and twenty‐one dogs with BCLL diagnosed by flow cytometry. Three breed groups were represented: small breed dogs (n = 55) because of increased risk of BCLL; Boxers (n = 33) because of preferential use of unmutated immunoglobulin genes; and other breeds (n = 33). Methods Retrospective study reviewing signalment, clinicopathologic data, physical examination findings, treatment, and survival of dogs with BCLL. Cellular proliferation, determined by the percentage of Ki67‐expressing CD21+ B‐cells by flow cytometry, was measured in 39 of 121 cases. Clinical and laboratory variables were evaluated for association with survival. Results The median survival time (MST) for all cases was 300 days (range, 1‐1644 days). Boxers had significantly shorter survival (MST, 178 days) than non‐Boxers (MST, 423 days; P < .0001), and no significant survival difference was found between small breeds and other non‐Boxer breeds. Cases with high Ki67 (>40% Ki67‐expressing B‐cells) had significantly shorter survival (MST, 173 days) than did cases with 60 000 lymphocytes/μL) or clinical signs at presentation had significantly shorter survival. Conclusions and Clinical Importance B‐cell chronic lymphocytic leukemia had a variable clinical course and Boxer dogs and cases with high Ki67 had more aggressive disease.